UroGen Pharma Ltd. (URGN)
NASDAQ·Healthcare·Biotechnology
$29.72
+1.20%
Mkt Cap $1.45B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (11 analysts)
$40.00
Range $40.00 – $40.00
Implied Upside
+34.6%
Consensus $40.00 vs current $29.72
NASDAQ·Healthcare·Biotechnology
$29.72
+1.20%
Mkt Cap $1.45B
Buy
8
Hold
0
Sell
0
Price Target (11 analysts)
$40.00
Range $40.00 – $40.00
+34.6%
Consensus $40.00 vs current $29.72